Log in

Bladder cancer

Nomogram aids clinical decision making after radical cystectomy

  • News & Views
  • Published:

From Nature Reviews Urology

View current issue Sign up to alerts

Accurate estimates of treatment success, complications and long-term morbidity are essential for patients to make informed medical decisions regarding treatment. Several multivariate prediction models have been developed to predict patient outcome after radical cystectomy (RC) for bladder cancer. The IBCNC postcystectomy nomogram can improve clinical decision making and therefore patient outcome. The inclusion of biomarkers might improve the accuracy of nomogram predictions in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (France)

Instant access to the full article PDF.

References

  1. Shariat, S. F., Karakiewicz, P. I., Roehrborn, C. G. & Kattan, M. W. An updated catalog of prostate cancer predictive tools. Cancer 113, 3075–3099 (2008).

    Article  PubMed  Google Scholar 

  2. Shariat, S. F., Margulis, V., Lotan, Y., Montorsi, F. & Karakiewicz, P. I. Nomograms for bladder cancer. Eur. Urol. 54, 41–53 (2008).

    Article  PubMed  Google Scholar 

  3. Karakiewicz, P. I. et al. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. J. Urol. 176, 1354–1361; discussion 1361–1362 (2006).

    Article  PubMed  Google Scholar 

  4. Shariat, S. F. et al. Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin. Cancer Res. 12, 6663–6676 (2006).

    Article  PubMed  Google Scholar 

  5. International Bladder Cancer Nomogram Consortium, Bochner, B. H., Kattan, M. W. & Vora, K. C. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J. Clin. Oncol. 24, 3967–3972 (2006).

    Article  PubMed  Google Scholar 

  6. Vickers, A. J., Cronin, A. M., Elkin, E. B. & Gonen, M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med. Inform. Decis. Mak. 8, 53 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Vickers, A. J. et al. Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach. Cancer 115, 5460–5469 (2009).

    Article  PubMed  Google Scholar 

  8. Shariat, S. F. et al. Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy. Cancer 112, 315–325 (2008).

    Article  PubMed  Google Scholar 

  9. Margulis, V. et al. Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer. J. Natl Cancer Inst. 101, 114–119 (2009).

    Article  PubMed  Google Scholar 

  10. Karam, J. A. et al. Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy. Lancet Oncol. 8, 128–136 (2007).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shahrokh F. Shariat.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shariat, S., Tilki, D. Nomogram aids clinical decision making after radical cystectomy. Nat Rev Urol 7, 182–184 (2010). https://doi.org/10.1038/nrurol.2010.42

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2010.42

  • Springer Nature Limited

Navigation